Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

CMS Drug Plan Comparison Website Will Provide Cost-Lowering Suggestions

  • News

Executive Summary

The Centers for Medicare & Medicaid Services' Medicare drug plan comparison website will help beneficiaries save money by recommending generics and preferred drugs, CMS Division of Finance Operations, Pharmacy Group Director Babette Edgar said June 21

You may also be interested in...



Medicare Rx Plan Comparison Website Will Allow Online Enrollment

Medicare beneficiaries will be able to enroll in the Part D prescription drug plan of their choice directly through the program's plan comparison website

Medicare Rx Plan Comparison Website Will Allow Online Enrollment

Medicare beneficiaries will be able to enroll in the Part D prescription drug plan of their choice directly through the program's plan comparison website

Rx Price Comparisons Offered On Medicare Card Site For Eight Drug Classes

Medicare beneficiaries can compare the price of drugs in the same class for eight pharmaceutical categories following changes to the program's drug discount card website

Table

View full table

Topics

Tags:
BioPharmaceutical
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS045984

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By